The availability of organoids and spheroids may finally allow the study of downstream targets of somatostatin and IGF2 in I-NETs as well as the importance of candidate tumor genes like MIR1-2, RASSF1A, APC, or CDKN1B. This evidence concerns the gene RASSF1 and neoplasm.